Observational studyZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024
Cystatin C is associated with osteoporosis and fractures: An observational study based on Mendelian randomization analysis.
Observational study in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum CTRP3 and CysC correlate with glucose, lipid, and bone metabolism in elderly patients with type 2 diabetes mellitus complicated with osteoporosis.Journal of diabetes investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesOsteoporosis is characterized by decreased bone mass and damaged bone microstructure, often leading to fragility fractures. Low bone mineral density is a key risk factor for fractures. Serum cystatin C (CysC), an endogenous marker of glomerular filtration rate, is negatively correlated with bone mineral density and may be a potential risk factor for osteoporosis. This study aims to investigate the association and potential pathogenic mechanisms between CysC and osteoporosis and fractures in the general population by combining cohort analysis and Mendelian randomization (MR) analysis.
methodsLarge-scale prospective cohort data from the UK Biobank and summary statistics from genome-wide association study (GWAS) in European populations were utilized, with strict exclusion criteria applied (excluding non-white individuals, those with thyroid diseases, gastrointestinal dysfunction, kidney diseases, rheumatoid diseases, malignant tumors, chronic infections or inflammatory diseases, diabetes, hypertension, and individuals taking medications that affect bone metabolism). Multivariable linear regression, logistic regression, and Cox proportional hazards models were used to analyze the relationship between CysC and bone mineral density, osteoporosis, and fracture risk. All analyses were performed using three sequential models to adjust for confounding factors: Model 1 adjusted for demographic characteristics and lifestyle factors; Model 2 further adjusted for renal function based on Model 1; and Model 3 further adjusted for physical activity based on Model 2. Restricted cubic spline models were used to explore non-linear relationships, and MR analysis was conducted to assess the causal associations between CysC and osteoporosis and fractures.
resultsMultivariate analysis showed that after adjusting for basic variables (Model 1), there was no correlation between CysC and estimated bone mineral density (eBMD) in the overall study population; however, when stratified by gender, both males and females exhibited a significant negative correlation (
conclusionsElevated levels of CysC are significantly associated with an increased risk of osteoporosis and fractures, and this association is more pronounced in females. Renal function and physical activity levels may be important factors influencing this relationship. The link between CysC and osteoporosis and fractures may be mediated by several mechanisms: Eelevated CysC may lead to abnormalities in vitamin D and mineral metabolism, thereby inhibiting bone formation; renal dysfunction may exacerbate inflammation, affecting bone resorption; or in the osteoporosis state, increased osteoclast differentiation may result in elevated CysC levels. These findings support the potential use of CysC as a biomarker for predicting the risk of osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.